Cardiology
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Looking for a medical communications company? MedWrite International specializes in delivering global strategic medical marketing communications. Visit MedWrite's site to learn more.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 7.
Physicans awarded more than $92 million by CMS
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
More than 85,000 physicians and healthcare professionals, who properly reported data regarding Medicare services to the Center for Medicaid & Medicare Services (CMS), reaped more than $92 million in incentives in 2008 under the Physician Quality Reporting Initiative.
Source: Cardiovascular Business News - November 16, 2009 Category: Cardiology Tags: Latest News Source Type: news
Physicians awarded more than $92 million by CMSEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
More than 85,000 physicians and healthcare professionals, who properly reported data regarding Medicare services to the Center for Medicaid & Medicare Services (CMS), reaped more than $92 million in incentives in 2008 under the Physician Quality Reporting Initiative.
Source: Cardiovascular Business News - November 16, 2009 Category: Cardiology Tags: Latest News Source Type: news
Intestinal Sleeve May Improve Glycemic Control (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Noninvasively implanting a sleeve in the small intestine just beyond the stomach quickly improves glycemic control in obese diabetes patients, researchers say.
Source: MedPage Today Cardiovascular - November 16, 2009 Category: Cardiology Source Type: news
Study: Catheter-directed thrombolysis first option for pulmonary embolismEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The use of catheter-directed thrombolysis saves lives and should be considered a first-line treatment option for massive pulmonary embolism, according to a study in the November issue of the Journal of Vascular and Interventional Radiology.
Source: Cardiovascular Business News - November 16, 2009 Category: Cardiology Tags: Latest News Source Type: news
Check your pulseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Our new pulse check campaign is aimed at helping find people at hidden risk of stroke
Source: BHF National News - November 16, 2009 Category: Cardiology Source Type: consumer
CPR saves livesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We say giving emergency life support is still the right thing to do
Source: BHF National News - November 16, 2009 Category: Cardiology Source Type: consumer
The Medicines Company's Full Analysis Of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patient Outcomes Following PCIEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Medicines Company (NASDAQ: MDCO) announced the data from 13,941 patients treated in the discontinued CHAMPION Phase III program of cangrelor.
Source: Cardiovascular / Cardiology News From Medical News Today - November 16, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
AHA: Cangrelor fails to become a CHAMPION in two randomized, controlled trialsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, Fla.—The new, reversible antiplatelet drug cangrelor was not superior over clopidogrel in reducing the composite of death, MI or ischemic revascularization 48 hours after PCI, nor did the investigative drug prove superior over placebo for combined endpoint of MI, all-cause mortality and revascularization. Yet, the drug may have some benefits for stent thrombosis. Two randomized, controlled trials demonstrated these results, which were presented Sunday at the American Heart Association late breaking clinical trials session.
Source: Cardiovascular Business News - November 16, 2009 Category: Cardiology Tags: Latest News Source Type: news
'Scaffolding' Protein Changes In Heart Strengthen Link Between Alzheimer's Disease And Chronic Heart FailureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States. The international team of biochemists and cardiologists say they have identified three changes in the chemical make-up of a key structural protein, called desmin, in heart muscle cells in dogs.
Source: Cardiovascular / Cardiology News From Medical News Today - November 16, 2009 Category: Cardiology Tags: Alzheimer's / Dementia Source Type: news
Health Policy Research Round Up - Medicare And MassachusettsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Robert Wood Johnson Foundation: The Secrets of Massachusetts' Success - "By the summer of 2008, less than two years after Massachusetts' health reform law became effective, only 2.6 percent of state residents were uninsured - the lowest proportion ever recorded for any state.
Source: Cardiovascular / Cardiology News From Medical News Today - November 16, 2009 Category: Cardiology Tags: Medicare / Medicaid / SCHIP Source Type: news
Link Between Fat Around Organs And Decreased Heart FunctionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions. The study, which appears on-line in Obesity, also found that measuring a person's body mass index (BMI) does not reliably predict the amount of undesired fat in and around these vital organs.
Source: Cardiovascular / Cardiology News From Medical News Today - November 16, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Tiny Particles Can Deliver Antioxidant Enzyme To Injured Heart CellsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart. Injecting the enzyme-containing particles into rats' hearts after a simulated heart attack reduced the number of dying cells and resulted in improved heart function days later.
Source: Cardiovascular / Cardiology News From Medical News Today - November 16, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
New Mechanism Identified For Beneficial Effects Of Aspirin In Cardiovascular DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
On Sunday, November 15, 2009, Florida Atlantic University (FAU) researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science will present at the American Heart Association's Annual Scientific Sessions meeting in Orlando, FL, the first data in humans to show that all doses of aspirin used in clinical practice increase nitric oxide.
Source: Cardiovascular / Cardiology News From Medical News Today - November 16, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Columbia's 2009 Naomi Berrie Award For Diabetes ResearchEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Columbia University Medical Center presentED the 2009 Naomi Berrie Awards to a nationally recognized diabetes researcher, and a promising young investigator, for their outstanding achievements in diabetes research. The Award for Outstanding Achievement in Diabetes Research WENT to Richard Nathan Bergman, Ph.D, Professor and Chair of the Department of Physiology & Biophysics at the Keck School of Medicine of the University of Southern California (USC). Dr.
Source: Cholesterol News From Medical News Today - November 16, 2009 Category: Cardiology Tags: Diabetes Source Type: news
Clinical Trial Summary: Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT — Presented at AHA 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Although erythropoiesis-stimulating agents (ESAs) are widely used in patients with anemia and chronic kidney disease (CKD) who are not on dialysis, randomized data to support this approach are not available. The TREAT trial sought to test the hypothesis that the use of ESAs in patients with diabetes. . .
Source: Cardiosource - November 16, 2009 Category: Cardiology Source Type: organizations
FDA OKs Menstrual Drug LystedaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: FDA OKs Menstrual Drug LystedaCategory: Health NewsCreated: 11/16/2009 11:45:00 AMLast Editorial Review: 11/16/2009 11:45:22 AM
Source: MedicineNet Cholesterol General - November 16, 2009 Category: Cardiology Source Type: consumer
Alternative to Warfarin May Cut Risk of BleedingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Alternative to Warfarin May Cut Risk of BleedingCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Cholesterol General - November 16, 2009 Category: Cardiology Source Type: consumer
Sudden Cardiac Death Much More Likely to Strike MenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Sudden Cardiac Death Much More Likely to Strike MenCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Cholesterol General - November 16, 2009 Category: Cardiology Source Type: consumer
FDA OKs Menstrual Drug LystedaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: FDA OKs Menstrual Drug LystedaCategory: Health NewsCreated: 11/16/2009 11:45:00 AMLast Editorial Review: 11/16/2009 11:45:22 AM
Source: MedicineNet Heart General - November 16, 2009 Category: Cardiology Source Type: consumer
Experts Urge School Screening of Athletes' HeartsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Experts Urge School Screening of Athletes' HeartsCategory: Health NewsCreated: 11/15/2009 12:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Heart General - November 16, 2009 Category: Cardiology Source Type: consumer
Rapid Cooling Might Help Heart Attack PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Rapid Cooling Might Help Heart Attack PatientsCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Heart General - November 16, 2009 Category: Cardiology Source Type: consumer
New Wiring Adds Risk When Replacing PacemakerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: New Wiring Adds Risk When Replacing PacemakerCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Heart General - November 16, 2009 Category: Cardiology Source Type: consumer
Alternative to Warfarin May Cut Risk of BleedingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Alternative to Warfarin May Cut Risk of BleedingCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Heart General - November 16, 2009 Category: Cardiology Source Type: consumer
Sudden Cardiac Death Much More Likely to Strike MenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Sudden Cardiac Death Much More Likely to Strike MenCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Heart General - November 16, 2009 Category: Cardiology Source Type: consumer
Gene Linked to Breast Cancer Might Boost Heart HealthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Gene Linked to Breast Cancer Might Boost Heart HealthCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet Heart General - November 16, 2009 Category: Cardiology Source Type: consumer
Alternative to Warfarin May Cut Risk of BleedingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Alternative to Warfarin May Cut Risk of BleedingCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet High Blood Pressure General - November 16, 2009 Category: Cardiology Source Type: consumer
Sudden Cardiac Death Much More Likely to Strike MenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Sudden Cardiac Death Much More Likely to Strike MenCategory: Health NewsCreated: 11/15/2009 4:10:00 PMLast Editorial Review: 11/16/2009
Source: MedicineNet High Blood Pressure General - November 16, 2009 Category: Cardiology Source Type: consumer
AHA: Some platelet reactivity tests get thumbs up from new trialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, Fla.—Three out of six platelet function tests can identify heart patients whose platelet reactivity will increase heart risk, despite being pretreated with two anti-clotting drugs before PCI, according to a Sunday presentation during the late-breaking clinical session at the American Heart Association conference. The co-principal investigators told Cardiovascular Business News that their findings support more widespread use of platelet reactivity testing with these three tests.
Source: Cardiovascular Business News - November 16, 2009 Category: Cardiology Tags: Latest News Source Type: news
AHA: Rivaroxaban Drops Pro-Coagulation Factor in HF Patients (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Biomarkers of hypercoagulability -- an ominous sign in patients with heart failure -- appear to be reduced by treatment with the oral, direct Factor Xa inhibitor rivaroxaban, a researcher said at the AHA meeting here.
Source: MedPage Today Cardiovascular - November 16, 2009 Category: Cardiology Source Type: news
AHA: Rivaroxaban Drops Procoagulation Factor in HF Patients (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Biomarkers of hypercoagulability -- an ominous sign in patients with heart failure -- appear to be reduced by treatment with the oral, direct Factor Xa inhibitor rivaroxaban, a researcher said at the AHA meeting here.
Source: MedPage Today Cardiovascular - November 16, 2009 Category: Cardiology Source Type: news
AHA: Niacin Bests Ezetimibe as Add-On Therapy (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- In high-risk patients on long-term statin therapy, boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis than going for additional LDL cholesterol reductions by adding ezetimibe (Zetia), researchers here reported.
Source: MedPage Today Cardiovascular - November 16, 2009 Category: Cardiology Source Type: news
Olmetec 10, 20, 40mg tablets (olmesartan) - Revised SPCEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates > SPC Changes
Revised SPC includes changes to section 4.3 (Contraindications) and section 4.6 (Pregnancy and Lactation). Lactation is no longer listed as a contra-indication. Olmesartan is excreted in the milk of lactating rats but it is not known whether olmesartan is excreted in human milk. Because no information is available regarding the use of Olmetec during breast-feeding, Olmetec is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a...
Source: NeLM - Cardiovascular Medicine - November 16, 2009 Category: Cardiology Source Type: organizations
Procoralen 5mg, 7.5mg tablets (ivabradine) - Revised SPCEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates > SPC Changes
Revised SPC includes changes to:
Section 4.1 (Therapeutic indications) - the indication has been updated and the indication of ivabradine in combination with beta-blockers has been added.
Section 4.4 (Special warnings and precautions for use) - combination with calcium channel blockers. The paragraph Chronic heart failure has been updated
Section 5.1 (Pharmacodynamic Properties) - Two paragraphs have been added, refer to SPC for full details.
Source: NeLM - Cardiovascular Medicine - November 16, 2009 Category: Cardiology Source Type: organizations
Record AF: Clinical outcomes similar with rate-control and rhythm-control strategiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In recently diagnosed patients with atrial fibrillation, a rhythm-control strategy provides better therapeutic success versus a rate-control strategy, but this difference does not lead to improved clinical outcomes, results from the RecordAF survey show.
Source: MedWire News - Cardiology - November 16, 2009 Category: Cardiology Source Type: news
PLATO: Ticagrelor benefits seen in STEMI subanalysisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The investigational oral antiplatelet therapy ticagrelor significantly reduces the risk for major cardiovascular events and all-cause mortality compared with clopidogrel in patients with ST-segment elevation myocardial infarction and planned primary percutaneous coronary intervention, a predefined subanalysis of the PLATO trial shows.
Source: MedWire News - Cardiology - November 16, 2009 Category: Cardiology Source Type: news
Addition of extended-release niacin or ezetimibe to statin monotherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: NEJM
Area: News
Results from a trial comparing the effects of either niacin or ezetimibe added to long-term statin therapy on carotid intima-media thickness over a 14-month period have been published early online in the New England Journal of Medicine.
The ARBITER 6-HALTS (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies) trial enrolled adults (aged ? 30 years) who had either known atherosclerotic coronary or vascular disease (n=279) or a coronary heart disease risk equivalent, including diabetes mellitus (n=38); a 10-year Framing...
Source: NeLM - Cardiovascular Medicine - November 16, 2009 Category: Cardiology Source Type: organizations
Cangrelor, an anti-platelet drug in development, shows disappointing trial resultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: NEJM
Area: News
Two controlled trials of cangrelor, an anti-platelet drug in phase 3 trials, found it to be superior neither to placebo nor to a loading dose of clopidogrel when given before percutaneous coronary intervention (PCI).
The place of anti-platelet therapy in patients undergoing PCI is well established, however both the existing drugs used for pre-procedure loading (clopidogrel and prasugrel) require at least an hour for complete platelet inhibition, which is irreversible once it takes place. Many patients who might have PCI subsequently go on to CABG, and in these patients platelet inhibitio...
Source: NeLM - Cardiovascular Medicine - November 16, 2009 Category: Cardiology Source Type: organizations
Trans-catheter aortic valve implantation comes of ageEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Trans-catheter aortic valve implantation, using either of two commercially available bioprosthetic valves, has almost 100% success in the hands of interventionists trained in this technique, according to results of the first prospective registry to follow high-risk patients undergoing the procedure.
Source: MedWire News - Cardiology - November 16, 2009 Category: Cardiology Source Type: news
RAPTOR trial supports routine use of radial artery access for PCIEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Interventionists should be encouraged to use radial artery access for percutaneous coronary intervention, suggest data presented here at the 2009 American Heart Association Scientific Sessions in Orlando, Florida, USA.
Source: MedWire News - Cardiology - November 16, 2009 Category: Cardiology Source Type: news
POPULAR defines platelet function assays predictive of clopidogrel outcomesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers report that three available platelet function assays can identify patients receiving dual antiplatelet therapy who are at increased risk for major cardiovascular events related to poor clopidogrel response.
Source: MedWire News - Cardiology - November 16, 2009 Category: Cardiology Source Type: news
Journal Scan: Long-Term Effects of a Very Low-Carbohydrate Diet and a Low-Fat Diet on Mood and Cognitive Function (Arch Intern Med 2009;169:1873-1880.)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Subjects (ages 24-64 years) were randomized to an energy-restricted diet, isocaloric, very low-carbohydrate, high-fat diet or a high-carbohydrate, low-fat diet for 1 year. Subjects were excluded if they had a history of liver, cardiovascular, peripheral, respiratory, or gastrointestinal disease; dia. . .
Source: Cardiosource - November 16, 2009 Category: Cardiology Source Type: organizations
CVN: News from AHA 09Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AHA 2009 Meeting Coverage: Daily Wrap-up / Monday
Source: Cardiosource - November 16, 2009 Category: Cardiology Source Type: organizations
Prognostic Implications of Myocardial Perfusion Single-Photon Emission Computed Tomography in the Elderly.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Stress MPS effectively stratifies CD risk in elderly patients and may identify optimal post-MPS therapy. CD rates after normal MPS are low in all subsets in relative terms compared with the age-matched US population.
PMID: 19917890 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, Cohen I, Thomson LE, Germano G, Berman DS Tags: Circulation Source Type: journals
Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1-Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Our study demonstrates that DDAH1 is highly expressed in vascular endothelium and that endothelial DDAH1 plays an important role in regulating blood pressure. In the context that asymmetric methylarginines are broadly produced by many type of cells, the strong DDAH1 expression in vascular endothelium demonstrates for the first time that vascular endothelium can be an important site to actively dispose of toxic biochemical molecules produced by other types of cells.
PMID: 19917889 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Hu X, Xu X, Zhu G, Atzler D, Kimoto M, Chen J, Schwedhelm E, Lüneburg N, Böger RH, Zhang P, Chen Y Tags: Circulation Source Type: journals
Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). A Retrospective Analysis.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion-In this retrospective hypothesis-generating study, we found a significant interaction between hs-CRP and the effect of rosuvastatin for most end points whereby rosuvastatin treatment was associated with better outcomes in patients with hs-CRP >/=2.0 mg/L. Clinical Trial Registration Information-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00206310.
PMID: 19917888 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamensky G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J, Tags: Circulation Source Type: journals
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure. Analysis From the Sudden Cardiac Death in Heart Failure Trial.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-ICD therapy reduced cardiac mortality and sudden death presumed to be ventricular tachyarrhythmic in SCD-HeFT and had no effect on heart failure mortality. Amiodarone had no effect on all-cause mortality or its cause-specific components. Clinical Trial Registration Information-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000609.
PMID: 19917887 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH Tags: Circulation Source Type: journals
Priming With Angiopoietin-1 Augments the Vasculogenic Potential of the Peripheral Blood Stem Cells Mobilized With Granulocyte Colony-Stimulating Factor Through a Novel Tie2/Ets-1 Pathway.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-The short-term priming with COMP-Ang1 may be a feasible and promising option to activate (mob)PBSCs by enhancing differentiation and adhesiveness and to improve the efficacy of cell therapy for ischemic diseases.
PMID: 19917886 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, Lee SW, Suh JW, Park KW, Lee HY, Kang HJ, Lee DS, Koh GY, Nakagami H, Morishita R, Park YB, Kim HS Tags: Circulation Source Type: journals
Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion-MRMPI can detect functionally significant coronary heart disease with excellent sensitivity, specificity, and positive and negative predictive values compared with FFR.
PMID: 19917885 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Watkins S, McGeoch R, Lyne J, Steedman T, Good R, McLaughlin MJ, Cunningham T, Bezlyak V, Ford I, Dargie HJ, Oldroyd KG Tags: Circulation Source Type: journals
High Residual Platelet Reactivity After Clopidogrel Loading and Long-Term Clinical Outcome After Drug-Eluting Stenting for Unprotected Left Main Coronary Disease.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-HRPR after 600-mg clopidogrel loading is a strong marker of increased risk of cardiac death and DES thrombosis in patients receiving DES stenting for ULMD. Routine assessment of in vitro residual platelet reactivity after clopidogrel loading in patients with ULMD potentially suitable for DES-supported percutaneous coronary intervention should be considered to guide patient care decisions.
PMID: 19917884 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Migliorini A, Valenti R, Marcucci R, Parodi G, Giuliani G, Buonamici P, Cerisano G, Carrabba N, Gensini GF, Abbate R, Antoniucci D Tags: Circulation Source Type: journals
B-Type Natriuretic Peptides and Cardiovascular Risk. Systematic Review and Meta-Analysis of 40 Prospective Studies.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Available prospective studies indicate strong associations between circulating concentration of natriuretic peptides and CVD risk under a range of different circumstances. Further investigation is warranted, particularly in large general population studies, to clarify any predictive utility of these markers and to better control for publication bias.
PMID: 19917883 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J Tags: Circulation Source Type: journals
